Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

1995314 citationsJournal Article

Authors

The results indicate the existence of a therapeutic window in RA within the first 2 years of the disease.

Good health and well-being

Published in: PubMed

Volume 22, Issue 12, pp. 2208-13

Field-Weighted Citation Impact: 3.07